For research use only. Not for therapeutic Use.
BZAD-01（Cat No.:I012748）is a small molecule compound being developed for the treatment of cancer and other diseases associated with abnormal cell signaling. It works by targeting specific proteins involved in cell proliferation, survival, and tumor progression. By modulating key signaling pathways, BZAD-01 inhibits the growth of cancer cells and promotes cell death in tumors. Preclinical studies suggest its potential for use in solid tumors and hematological cancers. BZAD-01’s selective action on tumor-associated pathways offers a promising therapeutic strategy, with ongoing research focused on its safety, efficacy, and clinical application.
| CAS Number | 305339-41-7 |
| Synonyms | 4-(trifluoromethoxy)-N’-[[2-(trifluoromethyl)phenyl]methyl]benzenecarboximidamide |
| Molecular Formula | C16H12F6N2O |
| Purity | ≥95% |
| IUPAC Name | 4-(trifluoromethoxy)-N'-[[2-(trifluoromethyl)phenyl]methyl]benzenecarboximidamide |
| InChI | InChI=1S/C16H12F6N2O/c17-15(18,19)13-4-2-1-3-11(13)9-24-14(23)10-5-7-12(8-6-10)25-16(20,21)22/h1-8H,9H2,(H2,23,24) |
| InChIKey | YGOCAMFQDLFNQK-UHFFFAOYSA-N |
| SMILES | C1=CC=C(C(=C1)CN=C(C2=CC=C(C=C2)OC(F)(F)F)N)C(F)(F)F |
| Chemistry Calculators | Dilution Calculator In vivo Formulation Calculator Molarity Calculator Molecular Weight Calculator Reconstitution Calculator |
